ZA978450B - Medical treatment - Google Patents
Medical treatmentInfo
- Publication number
- ZA978450B ZA978450B ZA978450A ZA978450A ZA978450B ZA 978450 B ZA978450 B ZA 978450B ZA 978450 A ZA978450 A ZA 978450A ZA 978450 A ZA978450 A ZA 978450A ZA 978450 B ZA978450 B ZA 978450B
- Authority
- ZA
- South Africa
- Prior art keywords
- medical treatment
- medical
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Electrotherapy Devices (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9619757.9A GB9619757D0 (en) | 1996-09-21 | 1996-09-21 | Chemical process |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA978450B true ZA978450B (en) | 1999-03-19 |
Family
ID=10800326
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA978450A ZA978450B (en) | 1996-09-21 | 1997-09-19 | Medical treatment |
Country Status (26)
| Country | Link |
|---|---|
| US (3) | US6174925B1 (ja) |
| EP (1) | EP0927028A1 (ja) |
| JP (1) | JP2001503737A (ja) |
| KR (1) | KR20000048501A (ja) |
| CN (1) | CN1237905A (ja) |
| AU (1) | AU724488B2 (ja) |
| BG (1) | BG64473B1 (ja) |
| BR (1) | BR9711517A (ja) |
| CA (1) | CA2266401C (ja) |
| CZ (1) | CZ93699A3 (ja) |
| GB (1) | GB9619757D0 (ja) |
| HR (1) | HRP970505A2 (ja) |
| HU (1) | HUP9904026A3 (ja) |
| ID (1) | ID18320A (ja) |
| IL (1) | IL128850A (ja) |
| MY (1) | MY116150A (ja) |
| NO (1) | NO991358D0 (ja) |
| NZ (1) | NZ334580A (ja) |
| PL (1) | PL332305A1 (ja) |
| RU (1) | RU2245709C2 (ja) |
| SK (1) | SK31999A3 (ja) |
| TR (1) | TR199900618T2 (ja) |
| TW (1) | TW580385B (ja) |
| UA (1) | UA64726C2 (ja) |
| WO (1) | WO1998011884A1 (ja) |
| ZA (1) | ZA978450B (ja) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9619757D0 (en) * | 1996-09-21 | 1996-11-06 | Knoll Ag | Chemical process |
| ID27415A (id) * | 1998-06-30 | 2001-04-05 | Takeda Chemical Industries Ltd | Komposisi farmaseutik |
| JP2000080047A (ja) * | 1998-06-30 | 2000-03-21 | Takeda Chem Ind Ltd | 医 薬 |
| US6476078B2 (en) * | 1999-08-11 | 2002-11-05 | Sepracor, Inc. | Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction |
| US6339106B1 (en) | 1999-08-11 | 2002-01-15 | Sepracor, Inc. | Methods and compositions for the treatment and prevention of sexual dysfunction |
| US6974838B2 (en) | 1998-08-24 | 2005-12-13 | Sepracor Inc. | Methods of treating or preventing pain using sibutramine metabolites |
| US6331571B1 (en) | 1998-08-24 | 2001-12-18 | Sepracor, Inc. | Methods of treating and preventing attention deficit disorders |
| BR9915285A (pt) * | 1998-11-12 | 2001-08-07 | Smithkline Beecham Plc | Composição farmacêutica para liberação modificada de um sensitivador de insulina e um outro agente antidiabético |
| US20040102486A1 (en) * | 1998-11-12 | 2004-05-27 | Smithkline Beecham Corporation | Novel method of treatment |
| AR023699A1 (es) * | 1998-11-12 | 2002-09-04 | Smithkline Beecham Corp | Una composicion farmaceutica que comprende un estabilizador de insulina y un procedimiento para preparar una composicion farmaceutica |
| US6323242B1 (en) | 1998-12-02 | 2001-11-27 | Peter Sterling Mueller | Treatment of disorders secondary to organic impairments |
| US6696495B2 (en) | 1998-12-02 | 2004-02-24 | Snowden Pharmaceuticals, Llc | Treatment of disorders secondary to organic impairments |
| US6552087B1 (en) | 1999-03-19 | 2003-04-22 | Abbott Gmbh & Co. Kg | Therapeutic agent comprising (+)-sibutramine |
| US6680344B1 (en) | 1999-06-01 | 2004-01-20 | The University Of Texas Southwestern Medical Center | Method of treating hair loss using diphenylmethane derivatives |
| US6723717B1 (en) | 1999-06-01 | 2004-04-20 | The University Of Texas Southwestern Medical Center | Sulfur-containing thyroxane derivatives and their use as hair growth promotors |
| EP1185232A1 (en) | 1999-06-01 | 2002-03-13 | University Of Texas Southwestern Medical Center | Method of treating hair loss using sulfonyl thyromimetic compounds |
| US6399826B1 (en) | 1999-08-11 | 2002-06-04 | Sepracor Inc. | Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain |
| US6610887B2 (en) | 2001-04-13 | 2003-08-26 | Sepracor Inc. | Methods of preparing didesmethylsibutramine and other sibutramine derivatives |
| US8911781B2 (en) | 2002-06-17 | 2014-12-16 | Inventia Healthcare Private Limited | Process of manufacture of novel drug delivery system: multilayer tablet composition of thiazolidinedione and biguanides |
| MXPA05003355A (es) * | 2002-10-05 | 2005-10-18 | Hanmi Pharm Ind Co Ltd | Composicion farmaceutica que comprende semihidrato de metansulfonato de sibutramina cristalino. |
| US20050131074A1 (en) * | 2003-08-04 | 2005-06-16 | Beckman Kristen M. | Methods for treating metabolic syndrome |
| AR045330A1 (es) * | 2003-08-07 | 2005-10-26 | Sb Pharmco Inc | Forma de dosificacion oral, procedimiento para su preparacion y uso del compuesto 5-(4-(2-(n-metil-n- (2-piridil)amino)etoxi )bencil) tiazolidin-2,4-diona o una sal o solvato farmaceuticamente aceptable del mismo para prepararla |
| GB0318824D0 (en) * | 2003-08-11 | 2003-09-10 | Glaxo Group Ltd | Novel composition |
| ZA200602056B (en) | 2003-10-31 | 2007-05-30 | Takeda Pharmaceutical | Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester |
| KR100627687B1 (ko) * | 2005-04-20 | 2006-09-25 | 주식회사 씨티씨바이오 | 시부트라민 유리염기 함유 조성물 및 이의 제조방법 |
| RU2430913C2 (ru) * | 2006-01-06 | 2011-10-10 | Сепракор Инк. | Циклоалкиламины в качестве ингибиторов повторного поглощения моноамина |
| CA2663254C (en) | 2006-09-15 | 2016-04-19 | Reviva Pharmaceuticals, Inc. | Synthesis, methods of using, and compositions of cycloalkylmethylamines |
| US8604244B2 (en) | 2010-07-02 | 2013-12-10 | Reviva Pharmaceuticals, Inc. | Compositions, synthesis, and methods of using cycloalkylmethylamine derivatives |
| KR100812538B1 (ko) * | 2006-10-23 | 2008-03-11 | 한올제약주식회사 | 약물 제어방출형 메트포르민-글리메피리드 복합제제 |
| KR20080046601A (ko) * | 2006-11-22 | 2008-05-27 | 에스케이케미칼주식회사 | 보관안정성이 우수한 시부트라민 함유 포접복합체 |
| PT2118123E (pt) | 2007-01-31 | 2016-02-10 | Harvard College | Péptidos de p53 estabilizados e suas utilizações |
| EP2142562B1 (en) | 2007-03-28 | 2013-07-03 | President and Fellows of Harvard College | Stitched polypeptides |
| KR20130099938A (ko) | 2010-08-13 | 2013-09-06 | 에일러론 테라퓨틱스 인코포레이티드 | 펩티도미메틱 거대고리 |
| BR112014009418A2 (pt) | 2011-10-18 | 2017-04-18 | Aileron Therapeutics Inc | macrociclos peptidomiméticos |
| BR112014016122A8 (pt) | 2011-12-30 | 2017-07-04 | Reviva Pharmaceuticals Inc | composto, e, composição farmacêutica |
| JP6450192B2 (ja) | 2012-02-15 | 2019-01-09 | エイルロン セラピューティクス，インコーポレイテッド | トリアゾール架橋した、およびチオエーテル架橋したペプチドミメティック大環状化合物 |
| ES2817877T3 (es) | 2012-02-15 | 2021-04-08 | Aileron Therapeutics Inc | Macrociclos peptidomiméticos |
| CA2887285A1 (en) | 2012-11-01 | 2014-05-08 | Aileron Therapeutics, Inc. | Disubstituted amino acids and methods of preparation and use thereof |
| CN112245565A (zh) | 2014-09-24 | 2021-01-22 | 艾瑞朗医疗公司 | 拟肽大环化合物及其用途 |
| SG11201707750YA (en) | 2015-03-20 | 2017-10-30 | Aileron Therapeutics Inc | Peptidomimetic macrocycles and uses thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE52768B1 (en) * | 1981-04-06 | 1988-02-17 | Boots Co Ltd | 1-arylcyclobutylalkylamine compounds useful as therapeutic agents |
| GB8531071D0 (en) * | 1985-12-17 | 1986-01-29 | Boots Co Plc | Therapeutic compound |
| GB8704777D0 (en) * | 1987-02-28 | 1987-04-01 | Boots Co Plc | Medical treatment |
| JP2675573B2 (ja) * | 1988-03-31 | 1997-11-12 | 科研製薬株式会社 | 脳機能改善剤 |
| IE61928B1 (en) * | 1988-11-29 | 1994-11-30 | Boots Co Plc | Treatment of obesity |
| WO1995010292A1 (en) | 1993-10-14 | 1995-04-20 | Biomedica California, Inc. | Diabetes treatment and prophylaxis |
| US5459164A (en) * | 1994-02-03 | 1995-10-17 | Boots Pharmaceuticals, Inc. | Medical treatment |
| GB9619757D0 (en) * | 1996-09-21 | 1996-11-06 | Knoll Ag | Chemical process |
-
1996
- 1996-09-21 GB GBGB9619757.9A patent/GB9619757D0/en active Pending
-
1997
- 1997-09-15 CN CN97199787A patent/CN1237905A/zh active Pending
- 1997-09-15 CZ CZ99936A patent/CZ93699A3/cs unknown
- 1997-09-15 UA UA99042263A patent/UA64726C2/uk unknown
- 1997-09-15 HU HU9904026A patent/HUP9904026A3/hu unknown
- 1997-09-15 US US09/254,924 patent/US6174925B1/en not_active Expired - Lifetime
- 1997-09-15 TR TR1999/00618T patent/TR199900618T2/xx unknown
- 1997-09-15 NZ NZ334580A patent/NZ334580A/xx not_active IP Right Cessation
- 1997-09-15 IL IL12885097A patent/IL128850A/xx not_active IP Right Cessation
- 1997-09-15 JP JP51427198A patent/JP2001503737A/ja not_active Ceased
- 1997-09-15 RU RU99108468/14A patent/RU2245709C2/ru not_active IP Right Cessation
- 1997-09-15 PL PL97332305A patent/PL332305A1/xx unknown
- 1997-09-15 BR BR9711517A patent/BR9711517A/pt not_active IP Right Cessation
- 1997-09-15 KR KR1019990702397A patent/KR20000048501A/ko not_active Application Discontinuation
- 1997-09-15 CA CA002266401A patent/CA2266401C/en not_active Expired - Fee Related
- 1997-09-15 SK SK319-99A patent/SK31999A3/sk unknown
- 1997-09-15 WO PCT/EP1997/005039 patent/WO1998011884A1/en active Search and Examination
- 1997-09-15 EP EP97910288A patent/EP0927028A1/en not_active Ceased
- 1997-09-15 AU AU47740/97A patent/AU724488B2/en not_active Ceased
- 1997-09-18 HR HR9619757.9A patent/HRP970505A2/hr not_active Application Discontinuation
- 1997-09-19 ZA ZA978450A patent/ZA978450B/xx unknown
- 1997-09-20 MY MYPI97004383A patent/MY116150A/en unknown
- 1997-09-22 ID IDP973256A patent/ID18320A/id unknown
- 1997-09-24 TW TW086113897A patent/TW580385B/zh not_active IP Right Cessation
-
1999
- 1999-03-19 NO NO991358A patent/NO991358D0/no not_active Application Discontinuation
- 1999-03-24 BG BG103277A patent/BG64473B1/bg unknown
-
2000
- 2000-10-30 US US09/702,125 patent/US6617360B1/en not_active Expired - Fee Related
-
2003
- 2003-08-15 US US10/641,506 patent/US20040077730A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| SK31999A3 (en) | 1999-12-10 |
| GB9619757D0 (en) | 1996-11-06 |
| HUP9904026A2 (hu) | 2000-05-28 |
| US20040077730A1 (en) | 2004-04-22 |
| BR9711517A (pt) | 1999-08-24 |
| US6174925B1 (en) | 2001-01-16 |
| IL128850A (en) | 2003-07-31 |
| NO991358L (no) | 1999-03-19 |
| RU2245709C2 (ru) | 2005-02-10 |
| KR20000048501A (ko) | 2000-07-25 |
| MY116150A (en) | 2003-11-28 |
| BG103277A (en) | 2000-01-31 |
| CA2266401C (en) | 2007-01-30 |
| ID18320A (id) | 1998-03-26 |
| HUP9904026A3 (en) | 2000-07-28 |
| TW580385B (en) | 2004-03-21 |
| TR199900618T2 (xx) | 1999-06-21 |
| UA64726C2 (uk) | 2004-03-15 |
| CN1237905A (zh) | 1999-12-08 |
| EP0927028A1 (en) | 1999-07-07 |
| PL332305A1 (en) | 1999-08-30 |
| AU4774097A (en) | 1998-04-14 |
| WO1998011884A1 (en) | 1998-03-26 |
| BG64473B1 (bg) | 2005-04-30 |
| CA2266401A1 (en) | 1998-03-26 |
| NO991358D0 (no) | 1999-03-19 |
| CZ93699A3 (cs) | 1999-08-11 |
| AU724488B2 (en) | 2000-09-21 |
| JP2001503737A (ja) | 2001-03-21 |
| NZ334580A (en) | 2000-09-29 |
| US6617360B1 (en) | 2003-09-09 |
| IL128850A0 (en) | 2000-01-31 |
| HRP970505A2 (en) | 1998-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL128850A0 (en) | Medical treatment | |
| GB9411080D0 (en) | Treatment | |
| GB9617502D0 (en) | Medical devices | |
| GB9610682D0 (en) | Medical devices | |
| GB2303303B (en) | Medical treatment | |
| GB9521725D0 (en) | Medical treatment | |
| ZA953237B (en) | Medical treatment | |
| GB9608657D0 (en) | Novel treatment | |
| GB9526264D0 (en) | Medical treatment | |
| GB9617550D0 (en) | Medical ice-pack | |
| GB9626265D0 (en) | Medical treatment | |
| GB9621327D0 (en) | Medical treatment | |
| GB9618375D0 (en) | Medical treatment | |
| GB9626859D0 (en) | Medical treatment | |
| GB9612330D0 (en) | Medical treatment | |
| GB9602728D0 (en) | Medical treatment | |
| GB9601042D0 (en) | Medical use | |
| GB9710544D0 (en) | Medical treatment | |
| GB9425164D0 (en) | Medical treatment | |
| GB9403306D0 (en) | Medical treatment | |
| GB9421398D0 (en) | Medical treatment | |
| GB9424728D0 (en) | Medical treatment | |
| GB9425773D0 (en) | Medical treatment | |
| GB2307858B (en) | Medical treatment | |
| GB9612752D0 (en) | Novel treatment |